---
schema_version: "secwatch.filing_event.v1"
accession: "0001548123-24-000067"
form_type: "8-K"
ticker: "NUMD"
cik: "0001543637"
company_name: "Nu-Med Plus, Inc."
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:26:37.307181+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Nu-Med Plus completes acquisition of YourSpace America, new CEO and majority control shift

## Summary
- Nu-Med Plus acquires YourSpace America via share exchange; YSA becomes wholly owned subsidiary as of April 28, 2024.
- Consideration: 4.5M shares of Series A Preferred (convertible to 90M common shares, 20:1 voting) and 1M Series X Preferred (100:1 voting).
- Series X Preferred issued to William R. Colvin, granting him majority voting control of the combined company.
- William R. Colvin appointed President, CEO, and Director; former CEO William Hayde becomes Executive Chairman.
- An audit of YSA for the prior two fiscal years is pending; amended 8-K to be filed upon completion.

## SEC filing metadata
- accession: 0001548123-24-000067
- form_type: 8-K
- ticker: NUMD
- cik: 0001543637
- company_name: Nu-Med Plus, Inc.
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.01, 3.03, 3.02, 1.01, 5.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1543637/000154812324000067/0001548123-24-000067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1543637/000154812324000067/numd8-k42824.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001548123-24-000067
- JSON: https://secwatch.observer/filing/0001548123-24-000067.json
- Plain text: https://secwatch.observer/filing/0001548123-24-000067.txt

## Key facts
- Executive change
  William Hayde was appointed as Executive Chairman of the Board at Nu-Med Plus, Inc..
  - Action: appointed
  - Role: Executive Chairman of the Board
  source text: Following the appointment of Mr. Colvin as President and Chief Executive Officer, the Company’s former President and CEO William Hayde was appointed to serve as the Company’s Executive Chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1543637/000154812324000067/0001548123-24-000067-index.htm
- Executive change
  William R. "Russ" Colvin was appointed as President, Chief Executive Officer, and Director at Nu-Med Plus, Inc..
  - Action: appointed
  - Role: President, Chief Executive Officer, and Director
  source text: the Board of Directors of the Company appointed William R. “Russ” Colvin as the Company’s President, Chief Executive Officer, and Director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1543637/000154812324000067/0001548123-24-000067-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.